MicroRNAs circulating in blood could lead to first diagnostic test for asthma – News-Medical.net

MicroRNAs circulating in blood could lead to first diagnostic test for asthma
News-Medical.net
People with asthma have telltale molecules circulating in their blood, say researchers at Penn State College of Medicine. The discovery could lead to the first diagnostic blood test for asthma, as well as more targeted treatments for the condition

View full post on asthma – Google News

Adult Orbital Xanthogranulomatous Disease: A Review with Emphasis on Etiology, Systemic Associations, Diagnostic Tools, and Treatment.

Adult Orbital Xanthogranulomatous Disease: A Review with Emphasis on Etiology, Systemic Associations, Diagnostic Tools, and Treatment.

Dermatol Clin. 2015 Jul;33(3):457-63

Authors: Kerstetter J, Wang J

Abstract
Adult orbital xanthogranulomatous diseases are rare entities and encompass a group of disorders with varying manifestations that are poorly understood. Taken as a group, there are non-Langerhans histiocytic disorders (type II) that are diagnosed histologically by the presence of foamy histiocytes, Touton giant cells, and varying degrees of fibrosis. Based on the accompanying systemic associations, there are 4 main categories of adult xanthogranulomatous disease: adult-onset xanthogranuloma, adult-onset asthma and periocular xanthogranuloma, necrobiotic xanthogranuloma, and Erdheim-Chester disease. Herein, we discuss the etiopathogenesis, systemic associations, methods of diagnosis, and treatment options for these disorders.

PMID: 26143425 [PubMed – in process]

View full post on pubmed: asthma

AstraZeneca (AZN), Abbott (ABT) to Develop Diagnostic Tests for Asthma Patients – StreetInsider.com

AstraZeneca (AZN), Abbott (ABT) to Develop Diagnostic Tests for Asthma Patients
StreetInsider.com
AstraZeneca (NYSE: AZN) announced that it has entered an agreement with Abbott (NYSE: ABT), a global healthcare company, to develop companion diagnostic tests to identify patients with severe asthma who are most likely to benefit from the …
AstraZeneca Enters Companion Diagnostic Test Deal With AbbottLondon South East

all 3 news articles »

View full post on asthma – Google News

Simple diagnostic tool for asthma,COPD remains unknown: Survey – Indian Express

Simple diagnostic tool for asthma,COPD remains unknown: Survey
Indian Express
Spirometry, a dignostic tool for asthma and chronic obstructive pulmonary disease (COPD) remains poorly utilised in clinical practice, with few people having
Lung Disease: Leading Health Concern in Ontario Often Canada NewsWire (press release)
Are your lungs in good shape?Channel Television
Free tests will determine lung functionChampaign/Urbana News-Gazette

all 8 news articles »

View full post on asthma – Google News